BioIVT, formerly BioreclamationIVT, is a leading global provider of high-quality biological specimens and value-added services. We specialize in control and disease state samples including human and animal tissues, cell products, blood and other biofluids. Our unmatched portfolio of clinical specimens directly supports precision medicine research and the effort to improve patient outcomes by coupling comprehensive clinical data with donor samples. Our Research Services team works collaboratively with clients to provide in vitro hepatic modeling solutions. And as the world’s premier supplier of ADME-Tox model systems, including hepatocytes and subcellular fractions, BioIVT enables scientists to better understand the pharmacokinetics and drug metabolism of newly discovered compounds and the effects on disease processes. By combining our technical expertise, exceptional customer service, and unparalleled access to biological specimens, BioIVT serves the research community as a trusted partner in ELEVATING SCIENCE®.
Looking for a particular BioIVT employee's phone or email?
The BioIVT annual revenue was $29.5 million in 2026.
Auro Nair is the CEO of BioIVT.
323 people are employed at BioIVT.
BioIVT is based in Woodbury, New York.
The NAICS codes for BioIVT are [32541, 54171, 3254, 325414, 32, 5417, 541, 325, 54, 541711].
The SIC codes for BioIVT are [2834, 28, 87, 873, 283].